Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2018

01-10-2018 | Original Article

Association of HSD11B1 rs12086634 and HSD11B1 rs846910 gene polymorphisms with polycystic ovary syndrome in South Indian women

Authors: Nayana Devang, Kapaettu Satyamoorthy, Padmalatha S. Rai, M. Nandini, Arindam Basu, Prabha Adhikari

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2018

Login to get access

Abstract

The 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme generates cortisol from cortisone for local glucocorticoid action in hepatocytes and adipocytes. Functional polymorphisms within 11beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene have shown an association with various factors including insulin resistance, diabetes, and obesity. In this study, we have assessed a candidate gene association study in order to examine the association of HSD11B1 gene polymorphisms with polycystic ovary syndrome (PCOS). A total of 200 women were investigated in this case-control study. DNA samples from PCOS women (n = 100) and the age-matched control women (n = 100) were analyzed. Genotyping of HSD11B1 rs12086634 and rs846910 variants was performed using tetra-primer amplification refractory mutation system (TETRA-ARMS) PCR. Odds ratio and 95% confidence interval were calculated to determine the association of HSD11B1 gene polymorphisms with polycystic ovary syndrome. The association analysis indicate that HSD11B1 rs12086634 showed positive association with polycystic ovary syndrome (OR = 1.95; 95%CI = 1.11–3.44, p = 0.0195) and women with HSD11B1 rs12086634 TG genotype had significantly higher body mass index (28.05 kg/mt2, p = 0.001), higher waist circumference (89.68 cms, p = 0.019), higher triglycerides (120.37 mg/dl, p = 0.049), and lower HDL levels (45.56 mg/dl, p = 0.004) compared to the women with HSD11B1 TT genotype. HSD11B1 rs846910 did not show any association with PCOS (OR = 0.57; 95%CI = 0.311–1.051, p = 0.072). Our results suggest that HSD11B1 rs12086634 polymorphism is associated with PCOS and HSD11B1 rs846910 gene polymorphism is not associated with PCOS in South Indian women.
Literature
2.
go back to reference Vassiliadi DA, Barber TM, Hughes BA, McCarthy MI, Wass JAH, Franks S, et al. Increased 5 alpha reductase activity and adrenocortical drive in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(9):3558–66. https://doi.org/10.1210/jc.2009-0837. Vassiliadi DA, Barber TM, Hughes BA, McCarthy MI, Wass JAH, Franks S, et al. Increased 5 alpha reductase activity and adrenocortical drive in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2009;94(9):3558–66. https://​doi.​org/​10.​1210/​jc.​2009-0837.
9.
go back to reference Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, et al. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 2003;34(4):434–9. https://doi.org/10.1038/ng1214. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, et al. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 2003;34(4):434–9. https://​doi.​org/​10.​1038/​ng1214.
12.
go back to reference Gambineri A, Tomassoni F, Munarini A, Stimson RH, Mioni R, Pagotto U, et al. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. Eur J Endocrinol. 2011;165(2):283–92. https://doi.org/10.1530/EJE-11-0091. Gambineri A, Tomassoni F, Munarini A, Stimson RH, Mioni R, Pagotto U, et al. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome. Eur J Endocrinol. 2011;165(2):283–92. https://​doi.​org/​10.​1530/​EJE-11-0091.
15.
go back to reference Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, et al. Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(6):2295–302. https://doi.org/10.1210/jc.2005-2222. Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, et al. Genetic variation in 11β-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(6):2295–302. https://​doi.​org/​10.​1210/​jc.​2005-2222.
16.
go back to reference Revised 2003. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.CrossRef Revised 2003. consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.CrossRef
18.
go back to reference Obel AO. Body mass index in non-insulin dependent diabetics in Kenya. Trop Geogr Med. 1988;40(2):93–6.PubMed Obel AO. Body mass index in non-insulin dependent diabetics in Kenya. Trop Geogr Med. 1988;40(2):93–6.PubMed
21.
go back to reference Sambrook J. Isolation of high-molecular weight DNA from mammalian cells. In: Nolan C, editor. Molecular cloning. New York: a laboratory manual Cold Spring Harbor Press; 1989. p. 9.16–9. Sambrook J. Isolation of high-molecular weight DNA from mammalian cells. In: Nolan C, editor. Molecular cloning. New York: a laboratory manual Cold Spring Harbor Press; 1989. p. 9.16–9.
25.
go back to reference Rong J, Wei W, Tang Q, Wu D. Association analysis between the polymorphisms of HSD11B1 and H6PD and risk of polycystic ovary syndrome in Chinese population. PLoS One. 2015;10(10):e0140326.CrossRef Rong J, Wei W, Tang Q, Wu D. Association analysis between the polymorphisms of HSD11B1 and H6PD and risk of polycystic ovary syndrome in Chinese population. PLoS One. 2015;10(10):e0140326.CrossRef
26.
go back to reference San Millan JL, Jose I, Botella-Carretero, Alvarez-Blasco F, et al. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-Hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(7):4157–62. https://doi.org/10.1210/jc.2004-1523.CrossRefPubMed San Millan JL, Jose I, Botella-Carretero, Alvarez-Blasco F, et al. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-Hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(7):4157–62. https://​doi.​org/​10.​1210/​jc.​2004-1523.CrossRefPubMed
34.
go back to reference Kambalachenu HR, Paul SFD, Nellepalli SR, Venkatachalam P. Study on follicle stimulating hormone receptor gene polymorphisms in South Indian women with polycystic ovary syndrome. Curr Res Med. 2013;4:60–7.CrossRef Kambalachenu HR, Paul SFD, Nellepalli SR, Venkatachalam P. Study on follicle stimulating hormone receptor gene polymorphisms in South Indian women with polycystic ovary syndrome. Curr Res Med. 2013;4:60–7.CrossRef
Metadata
Title
Association of HSD11B1 rs12086634 and HSD11B1 rs846910 gene polymorphisms with polycystic ovary syndrome in South Indian women
Authors
Nayana Devang
Kapaettu Satyamoorthy
Padmalatha S. Rai
M. Nandini
Arindam Basu
Prabha Adhikari
Publication date
01-10-2018
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2018
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-017-0596-8

Other articles of this Issue 4/2018

International Journal of Diabetes in Developing Countries 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.